NCT07381153尚未招募不适用
Cytotoxicity Evaluation of INOX (Nanoksa G Plus) High-Performance Polymer Discs on Cell Cultures: An In-Vitro Experimental Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Cell viability
研究概览
简要总结
This study aims to evaluate the cytotoxicity of INOX (Nanoksa G Plus) high-performance polymer discs on cell cultures using standardized in-vitro assays. The primary objective is to assess cell viability after exposure to INOX extracts. Secondary objectives include examining cell membrane integrity, cellular morphology, comparing effects across extract concentrations, and determining whether INOX meets accepted non-cytotoxicity standards.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •To assess cell viability following exposure to INOX material extracts using a quantitative cell viability assay.
排除标准
- •To evaluate cell membrane integrity following exposure to INOX extracts. To assess cellular morphology after exposure to the material. To compare cytotoxic effects at different extract concentrations. To determine whether INOX meets accepted non-cytotoxicity thresholds.
结局指标
主要结局
Cell viability
时间窗: JANUARY 2026
Cell viability, assessed using a quantitative assay (MTT, XTT, or Alamar Blue).
次要结局
未报告次要终点
研究者
Ghada Adayil
Lecturer of Periodontology, Faculty of Dentistry, Cairo University , Cairo, Egypt
Cairo University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Assessment of Cytotoxicity, GenotoxicityNCT07330401Yaxin Wang60
招募中
不适用
Advanced NanoTherapies Dual-API DCB to Treat De-Novo and ISR Lesions in Patients With Symptomatic Coronary Artery DiseaseUnstable AnginaNCT07368933Advanced NanoTherapies30
招募中
2 期
Pilot Study to Evaluate Safety and Efficacy of PolyCore, a Ternary Combination of Xylitol, L-Carnitine and Polydextrin, to Treat End-Stage Kidney Disease Patients Starting Peritoneal Dialysis (EXCITE)2024-519366-52-00Iperboreal Pharma S.r.l.28
进行中（未招募）
1/2 期
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with other anticancer agents in patients with HER2-positive Metastatic Breast Cancer inclusive of patients with active and stable brain metastases2023-505309-18-00AstraZeneca AB46
招募中
1 期
Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001Meningeal MetastasisNCT07264569Henan Cancer Hospital42